Bacteria Risk Spurs Recall of 8 Million Laundress Products
MONDAY, Dec. 5, 2022 -- The Laundress, a laundry and cleaning products company, has recalled nearly 8 million of its products over concerns they may be contaminated with various bacteria.
The bacteria include Burkholderia cepacia complex, Klebsiella... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 5, 2022 Category: Pharmaceuticals Source Type: news
Bacteria Risk Spurs Recall of 8 Million Laundress Products
MONDAY, Dec. 5, 2022 – The Laundress, a laundry and cleaning products company, has recalled nearly 8 million of its products over concerns they may be contaminated with various bacteria.
The bacteria include Burkholderia cepacia complex,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 5, 2022 Category: General Medicine Source Type: news
South Florida Federal Judge Orders Prison Time for Former Pharmatech CEO
FDA OCI, Raidel Figueroa, sentence, owner, Pharmatech, Broward County, FL, drug manufacture, lied, FDA, contaminated, products, pediatric, hospitals, Diocto, Liquid, outbreak, infections, bacteria, Burkholderia cepacia, B. cepacia, respiratory, infections, lies, upgrade, water, system, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - September 6, 2022 Category: Medical Law Authors: DOJ Source Type: news
Former CEO of Drug Manufacturing Company Charged with Conspiring to Defraud the FDA and Distributing Adulterated Drugs
FDA OCI, Raidel Figueroa, CEO, co-owner, Pharmatech, LLC, drug, dietary supplement, manufacturer, Broward County, FL, conspiracy, fraud, Diocto Liquid, constipation, investigation, outbreak, Burkholderia cepacia, B. cepacia, infections, bacteria, contaminated, lies, FDA, pediatric patients, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - April 5, 2022 Category: Medical Law Authors: DOJ Source Type: news
FDA Warns Clinicians to Stop Using Eco-Med Products FDA Warns Clinicians to Stop Using Eco-Med Products
Ultrasound gels and lotions manufactured by Eco-Med have been associated with nearly 60 infections with Burkholderia cepacia complex.News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 19, 2021 Category: Cancer & Oncology Tags: Radiology News Alert Source Type: news
FDA Warns Providers to Stop Using Eco-Med Products FDA Warns Providers to Stop Using Eco-Med Products
Ultrasound gels and lotions manufactured by Eco-Med have been associated with nearly 60 infections with Burkholderia cepacia complex.News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 19, 2021 Category: Cancer & Oncology Tags: Radiology News Alert Source Type: news
CDC Reports Burkholderia cepacia and B pseudomallei Outbreaks CDC Reports Burkholderia cepacia and B pseudomallei Outbreaks
The B cepacia infections were linked to contaminated ultrasound gel. The source of the B pseudomallei infections is unknown, but two of the four patients have died.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 13, 2021 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Centurion Labs Issues Voluntary Nationwide Recall of Ninjacof (Lot # 200N1601) and Ninjacof A (Lot# 201NA1601) Products Due to Potential Burkholderia Cepacia Contamination
Centurion Labs is voluntarily recalling, as a precautionary measure, 1 lot of Ninjacof (Lot# 200N1601) and 1 lot of Ninjacof A (Lot# 201NA1601) manufactured by Vilvet (Dania Beach, FL) and distributed by Centurion Labs to the retail level due to potential contamination with Burkholderia cepacia. Centurion was notified by the FDA regarding the potential contamination as they discovered this product may have been manufactured in a Pharmatech, FDA registered facility, in Davie, FL. that was found to have a product that contained B. cepacia. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 14, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Mid Valley Pharmaceutical LLC Issues Voluntary Recall of Doctor Manzanilla Cough & Cold and Doctor Manzanilla Allergy & Decongestant Relief Syrup Due to Potential Contamination with Burkholderia Cepacia
Mid Valley Pharmaceutical is recalling lot# 23221701 of Doctor Manzanilla Cough& Cold and lot# 23221701 of Doctor Manzanilla Allergy& Decongestant Relief syrup to the consumer level. The products may potentially be contaminated with the bacteria Burkholderia cepacia. Contaminated products with Burkholderia cepacia can potentially result in serious infections, may be life-threating in patients with compromised immune systems. To date, Mid Valley Pharmaceutical, LLC has not received any reports of adverse events related to this recall. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 5, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis
Review located one suitable RCT (n=100) which found that inhaled aztreonam lysine did not improve FEV1 and time to next exacerbation vs placebo. Authors therefore conclude that there is insufficient evidence to determine an effective antibiotic strategy for this infection. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 8, 2019 Category: Consumer Health News Source Type: news
Rugby Laboratories Issues Voluntary Nationwide Recall of Diocto Liquid and Diocto Syrup Manufactured By PharmaTech, LLC Due to Possible Product Contamination
Rugby ® Laboratories of Livonia, MI is voluntarily recalling all lots within the expiry of Diocto Liquid and Diocto Syrup, (docusate sodium solutions) manufactured by PharmaTech, LLC of Davie, FL due to a risk of product contamination with Burkholderia cepacia. If a product contains B. cepacia, its use c ould result in infections in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis. Some of these infections may be serious or even life-threatening in the at-risk patient population. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 5, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Hellolife, Inc. Issues Voluntary Worldwide Recall of Neuroveen, Respitrol, Thyroveev and Compulsin due to Possible Microbial Contamination
HelloLife, Inc. in Grand Rapids, MI is initiating a voluntary recall of four different products, Neuroveen, Respitrol, Thyroveev and Compulsin, within expiry, to the retail and consumer level due to possible microbial contamination. Neuroveen has been tested and found to be contaminated with Staphylococcus saprophyticus and Burkholderia cepacia. Compulsin has been identified as containing Burkholderia cepacia.
Respitrol and Thyroveev are still pending bacterial identification. Each product being recalled is for a single lot that was packaged into 2-ounce amber bottles (see table below) that were manufactured at the King Bi...
Source: FDA Center for Drug Evaluation and Research - What's New - May 23, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Hellolife, Inc. Issues Voluntary Worldwide Recall of Neuroveen, Respitrol, Thyroveev and Compulsin due to Possible Microbial Contamination
HelloLife, Inc. in Grand Rapids, MI is initiating a voluntary recall of four different products, Neuroveen, Respitrol, Thyroveev and Compulsin, within expiry, to the retail and consumer level due to possible microbial contamination. Neuroveen has been tested and found to be contaminated with Staphylococcus saprophyticus and Burkholderia cepacia. Compulsin has been identified as containing Burkholderia cepacia.
Respitrol and Thyroveev are still pending bacterial identification. Each product being recalled is for a single lot that was packaged into 2-ounce amber bottles (see table below) that were manufactured at the King B...
Source: Food and Drug Administration - August 29, 2018 Category: Food Science Source Type: news
An Eradication Protocol for B. Cepacia Complex in CF An Eradication Protocol for B. Cepacia Complex in CF
The authors describe a protocolized approach that effectively eradicated Burkholderia cepacia complex in cystic fibrosis patients.BMC Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 2, 2018 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news
Mid Valley Pharmaceutical LLC Issues Voluntary Recall of Doctor Manzanilla Cough & Cold and Doctor Manzanilla Allergy & Decongestant Relief Syrup Due to Potential Contamination with Burkholderia Cepacia.
Mid Valley Pharmaceutical is recalling lot# 23221701 of Doctor Manzanilla Cough& Cold and lot# 23221701 of Doctor Manzanilla Allergy& Decongestant Relief syrup to the consumer level. The products may potentially be contaminated with the bacteria Burkholderia cepacia. Contaminated products with Burkholderia cepacia can potentially result in serious infections, may be life-threating in patients with compromised immune systems. To date, Mid Valley Pharmaceutical, LLC has not received any reports of adverse events related to this recall. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 30, 2017 Category: Food Science Source Type: news
